Three projects – including the Oxford-led MyMelanoma study – have been selected to join an NHS initiative, which aims to sign up tens of thousands of volunteers over the next two years to help improve the diagnosis and treatment of cancer patients.
2024
Sunday Brunch with Professor Richard Scolyer AO
Simon visits Australian of the Year 2024 and co-medical director at the Melanoma Institute Australia Professor Richard Scolyer AO for Sunday Brunch.
What Is Known About Psychosocial Wellbeing in Patients With Melanoma In Situ?
A significant gap in research on psychosocial wellbeing among patients newly diagnosed with melanoma in situ (MIS) exists, according to the results of a systematic review published in Melanoma Research.
Lymphoid Aggregates as Positive Prognostic in Overall Survival for Melanoma
Because the prevalence and impact of immature precursor lymphoid structures known as lymphoid aggregates (LAs) remain unresolved in relation to metastatic cutaneous melanoma disease progression, researchers examined the characteristics and prognostic ability of LAs and tertiary lymphoid structures (TLSs) in histologic samples from patients with melanoma.